Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lichen sclerosus.

G L Tasker1, F Wojnarowska

  • 1Department of Dermatology, Oxford Radcliffe Hospital, Oxford, UK. TaskerGL@aol.com

Clinical and Experimental Dermatology
|March 26, 2003
PubMed
Summary
This summary is machine-generated.

Lichen sclerosus is a chronic anogenital skin condition affecting all ages, often linked to autoimmune disorders. Potent topical corticosteroids are effective, but long-term monitoring is crucial due to potential malignancy risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The need for longer time horizons for cost-utility evaluation in bullous pemphigoid: reply from the authors.

The British journal of dermatology·2017
Same author

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.

The British journal of dermatology·2017
Same author

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Response to Letter by Prof. C.B.B. Bunker.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author

Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author

Current practice in treatment approach for bullous pemphigoid: comparison between national surveys from the Netherlands and the UK.

Clinical and experimental dermatology·2016
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026
See all related articles

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Lichen sclerosus is a chronic skin condition primarily affecting the anogenital area in men, women, and children.
  • Its etiology remains unknown, but it shows a strong association with autoimmune disorders and a genetic link to HLA DQ7.
  • The condition causes significant morbidity, including intractable symptoms, scarring, and psychosexual damage, posing diagnostic challenges, especially in differentiating from child sexual abuse.

Purpose of the Study:

  • To review the clinical presentation, underlying associations, and management of lichen sclerosus.
  • To highlight the challenges in diagnosis and treatment of this chronic condition.
  • To emphasize the need for a multidisciplinary approach and long-term patient monitoring.

Main Methods:

Related Experiment Videos

  • Literature review of lichen sclerosus.
  • Analysis of clinical signs and associations.
  • Evaluation of treatment efficacy and risks.

    • Main Results:

    • Potent topical corticosteroids demonstrate effectiveness in managing lichen sclerosus symptoms.
    • A 5% incidence of squamous cell carcinoma is noted, necessitating biopsy of suspicious lesions.
    • The impact of topical corticosteroids on malignancy risk and potential human papillomavirus (HPV) reactivation remains unclear.

    Conclusions:

    • Effective management requires potent topical corticosteroids and a multidisciplinary approach.
    • Long-term monitoring in dedicated clinics is essential for patients with lichen sclerosus.
    • Support groups can be beneficial for patient well-being and coping strategies.